To further confirm RASSF1A promoter methylation status in bladder cancer patient’s diagnosis, we carried out a meta-analysis of 10 studies involving 543 cases and 217 controls to derive a more precise estimation of the association. Here, RASSF1 is linked to urinary bladder carcinoma.